Home » Topics » BioWorld Science

BioWorld Science
RSS

New phase I trial studies DCP-001 in high-grade serous ovarian cancer

June 23, 2021

miR-126-3p has potential for diagnosing Parkinson's disease

June 23, 2021

Keros reports preliminary phase II data on KER-050 for MDS

June 23, 2021

Tiziana prepares for phase II trial of intranasal foralumab in severe COVID-19

June 23, 2021

RASSF1A and PRSS21 are diagnostic markers of TGCT

June 23, 2021

Sosei opens phase I trial of CGRP receptor antagonist HTL-0022562

June 23, 2021

Gemini reports data from ongoing phase IIa study on GEM-103 in GA secondary to dry AMD

June 23, 2021

New generation of antifungal membrane active peptides from combinatorial library screening

June 23, 2021

POLQ is next target for DNA damage response

June 23, 2021

DTx Pharma presents new compounds for DMD

June 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...